Agenda
Spring 2024 Conference
(September 2024 Agenda to be Released 9/4/2024)
WEDNESDAY, APRIL 3, 2024
All Times are EST Time Zone
8:30am // REGISTRATION AND BREAKFAST
9:00am // OPENING REMARKS - Josh Seidenfeld, Partner, Cooley
9:10am // KEYNOTE TALK - Dennis Purcell, Founder, Aisling Capital & Former Head of Healthcare Banking at JP Morgan and H&Q. TOPIC: The Beginning of Biotech 3.0
9:40am // Corporate Presentation - Predictive Oncology (Nasdaq: POAI)
9:55am // Corporate Presentation - Indaptus Therapeutics (Nasdaq: INDP)
10:10am // Corporate Presentation - GRI Bio (Nasdaq: GRI)
10:25am // Corporate Presentation - Lixte Biotechnology (LIXT)
10:40am // Corporate Presentation - Radiopharm Theranostics (RAD.XA)
10:55am // Corporate Presentation - Processa Pharmaceuticals (Nasdaq: PCSA)
11:10am // Corporate Presentation - Viska Bio
11:25am // Corporate Presentation - Likarda
11:40am // Corporate Presentation - Repair Biotechnologies
11:55am // Corporate Presentation - HKG Epitherapeutics
12:10pm // SPEAKERS - Steven Ferguson, Special Advisor, NIH Office of Technology Transfer, Dr. Michael Salgaller, Supervisor, Technology Analysis and Marketing Unit (TAMU), NCI/NIH. Topic: Beyond SBIRs: Leveraging the NIH to Improve Pipelines and Bottom Lines
12:40pm - LUNCH BREAK / PANEL DISCUSSION
12:55pm - INVESTOR PANEL DISCUSSION - Moderator: William Werkmeister, Partner, HRN. Panelists: Allan Gobbs, Founder and Managing Partner, ATEM Capital; Dr. Denis Patrick, Managing Partner, Pfizer Ventures; Dr. John Prufeta, Founder, CEO, and General Partner, Medical Excellence Capital; Dr. Blaine Robinson, Executive Director, TAP Program, The Leukemia & Lymphoma Society.
1:35pm // Corporate Presentation - AIM ImmunoTech (NYSE American: AIM)
1:50pm // Corporate Presentation - NeoImmuneTech (950220.KQ)
2:05pm // Corporate Presentation - Bexion Pharmaceuticals
2:20pm // Corporate Presentation - GeneVentiv Therapeutics
2:35pm // Corporate Presentation - Medicovestor
2:50pm // Corporate Presentation - Cairn Therapeutics
3:05pm // Corporate Presentation - Sorriso Pharmaceuticals
3:20pm // Corporate Presentation - PDX Pharmaceuticals
3:35pm // Corporate Presentation - Cytotheryx
3:50pm // Corporate Presentation - Helex
4:05pm // Corporate Presentation - Avirmax Biopharma
4:20pm // Corporate Presentation - Aspira Women's Health (AWH)
4:35pm // Corporate Presentation - Xylyx Bio
4:50pm // Corporate Presentation - Rasayana Therapeutics
5:05pm // Corporate Presentation - Faeth Therapeutics
5:20pm // Corporate Presentation - Geneius Biotechnology
5:35pm // SPEAKER - Dr. Alexander Rudensky, Chair, Immunology, Memorial Sloan Kettering Cancer Center.
6:00pm // SPEAKER - Alan Tamarelli and Geoff Spolyar, Partners at Cooley. Topic: Life Science Partnering – Review and Explanation of Trending Deal Types
6:25pm // CLOSING REMARKS
6:30pm // RECEPTION
THURSDAY, APRIL 4, 2024
All Times are EST Time Zone
8:30am // REGISTRATION AND BREAKFAST
9:00am // OPENING REMARKS
9:10am // KEYNOTE TALK - Dr. Pablo Lapuerta, CEO 4M Therapeutics, Frm Executive Director, Global Medical Affairs, BMS, Frm Executive Director, Global Epidemiology, BMS. Topic: A Renaissance in Neuroscience Drug Development
9:40am // Corporate Presentation - CervoMed (CRVO)
9:55am // Corporate Presentation - BrainStorm Therapeutics
10:10am // Corporate Presentation - Aruna Bio
10:25am // Corporate Presentation - NeuExcell Therapeutics
10:40am // Corporate Presentation - Advantage Therapeutics
10:55am // Corporate Presentation - Sinaptica Therapeutics
11:10am // Corporate Presentation - Starton Therapeutics
11:25am // Corporate Presentation - PredxBio
11:40am // Corporate Presentation - Espervita Therapeutics
11:55am // Corporate Presentation - VasoRx
12:10pm // Corporate Presentation - Rejuvenation Technologies
12:25pm // Corporate Presentation - Promontory Therapeutics
12:40pm // LUNCH BREAK /NCI TALK
12:50pm // SPEAKERS - Steven Ferguson, Special Advisor, NIH Office of Technology Transfer, Dr. Michael Salgaller, Supervisor, Technology Analysis and Marketing Unit (TAMU), NCI/NIH. Topic: NIH as Your Technology Development and Commercialization Partner
1:10pm // Corporate Presentation - DepYmed
1:25pm // Corporate Presentation - Cellphire Therapeutics
1:40pm // Corporate Presentation - Sen-Jam Pharmaceutical
1:55pm // Corporate Presentation - SciTech Development
2:10pm // Corporate Presentation - Adipo Therapeutics
2:25pm // Corporate Presentation - Azome Therapeutics
2:40pm // Corporate Presentation - Molecuar You
2:55pm // Corporate Presentation - Nuclera
3:10pm // Corporate Presentation - Anagenex
3:25pm // Corporate Presentation - Intact Therapeutics
3:40pm // Corporate Presentation - Immunyx Pharma
3:55pm // Corporate Presentation - Autonomix Medical (Nasdaq: AMIX)
4:10pm // Corporate Presentation - Moleculin Biotech (Nasdaq: MBRX)
4:25pm // Corporate Presentation - CNS Pharmaceuticals (Nasdaq: CNSP)
4:40pm // Corporate Presentation - Orbits Oncology
4:55pm // Corporate Presentation - Kinoxis Therapeutics
5:10pm // SPEAKER - Dr. Harvey I. Pass, Stephen E. Banner Professor of Thoracic Oncology, Vice-Chairman, Research, NYU Langone Medical Center. Topic: Novel Ideas/Platforms for the Prognosis of Lung Cancer
5:30pm // SPEAKER - Bill Roegge, Partner, Cooley. Topic: M&A
5:50pm // CLOSING REMARKS
6:00pm // RECEPTION